ramirez, I. (2022) “Benefits of a National Program for Adverse Drugs Reactions (ADRS) Surveillance in Diabetic Patients”, Journal of Drug Delivery and Therapeutics, 12(4-S), pp. 40–42. doi:10.22270/jddt.v12i4-S.5618.